We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+4.31%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.43B
AUM Growth
+$292M
Cap. Flow
+$65.8M
Cap. Flow %
4.59%
Top 10 Hldgs %
64.89%
Holding
82
New
14
Increased
33
Reduced
12
Closed
20

Top Buys

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$37.3M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$35M
3
AMRN
Amarin Corp
AMRN
+$19.9M
4
AMED
Amedisys
AMED
+$19.4M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$14.7M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$77.7M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$27.1M
3
NVST icon
Envista
NVST
+$21.6M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$17.9M
5
HLN icon
Haleon
HLN
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 76.06%
2 Miscellaneous 22.43%
3 Financials 0.95%
4 Communication Services 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GH icon
26
Guardant Health
GH
$21.7B
$11.3M 0.79%
483,098
+336,969
+231% +$9.62M
PCVX icon
27
Vaxcyte
PCVX
$8.9B
$11.2M 0.78%
299,050
+120,597
+68% +$5.12M
HUM icon
28
Humana
HUM
$46.3B
$11.1M 0.77%
22,762
+1,851
+9% +$915K
IONS icon
29
Ionis Pharmaceuticals
IONS
$10.1B
$10.8M 0.76%
303,369
+62,394
+26% +$2.34M
SWAV
30
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$10.3M 0.72%
+47,577
New +$9.27M
ELV icon
31
Elevance Health
ELV
$85.5B
$9.48M 0.66%
20,615
-7,427
-26% -$3.53M
THC icon
32
Tenet Healthcare
THC
$21.5B
$8.43M 0.59%
141,892
-112,694
-44% -$6.26M
MODN
33
DELISTED
MODEL N, INC.
MODN
$8.1M 0.56%
241,870
+23,990
+11% +$875K
HCA icon
34
HCA Healthcare
HCA
$90.5B
$7.36M 0.51%
+27,909
New +$7.09M
XENE icon
35
Xenon Pharmaceuticals
XENE
$5.81B
$7.28M 0.51%
203,272
-72,432
-26% -$2.68M
AMRX icon
36
Amneal Pharmaceuticals
AMRX
$6.11B
$7.2M 0.5%
5,183,046
+4,352,086
+524% +$8.67M
XBI icon
37
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$6.1M 0.43%
+80,000
New +$6.64M
PNTG icon
38
Pennant Group
PNTG
$1.3B
$6.03M 0.42%
+421,974
New +$5.29M
PBYI icon
39
Puma Biotechnology
PBYI
$468M
$5.99M 0.42%
1,938,088
+430,425
+29% +$1.62M
TARO
40
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$5.96M 0.42%
245,267
+19,805
+9% +$578K
ZLAB icon
41
Zai Lab
ZLAB
$2.93B
$5.72M 0.4%
+171,999
New +$6.6M
LQDA icon
42
Liquidia Corp
LQDA
$6.06B
$5.01M 0.35%
724,406
-566,507
-44% -$3.87M
AMN icon
43
PUT
AMN Healthcare
AMN
$1.34B
$3.32M 0.23%
+40,000
New +$3.77M
IQV icon
44
IQVIA
IQV
$43.1B
$2.87M 0.2%
14,416
+3,527
+32% +$754K
HSKA
45
DELISTED
Heska Corp
HSKA
$2.58M 0.18%
26,409
+6,934
+36% +$581K
BHVN icon
46
Biohaven
BHVN
$2.33B
$2.54M 0.18%
185,595
– –
MRUS
47
DELISTED
Merus
MRUS
$2.37M 0.17%
129,056
-55,500
-30% -$967K
MEDP icon
48
Medpace
MEDP
$16.8B
$2.19M 0.15%
+11,668
New +$2.41M
GOCO
49
DELISTED
GoHealth
GOCO
$2.04M 0.14%
125,053
+74,531
+148% +$1.15M
XOMA
50
DELISTED
Xoma
XOMA
$1.9M 0.13%
89,950
+3,077
+4% +$64.7K
1
2
3 4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Eversept Partners held 82 positions worth $1.43B, up 26% from $1.14B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Eversept Partners deployed $65.8M of net new capital in Q1 2023, opening 14 new positions and adding to 33 existing holdings. Its largest new stake was Amedisys: 224,263 shares worth $16.5M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 90% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $27.1M trimmed.

  • Eversept Partners's largest Q1 2023 buy was Amedisys: 224,263 shares worth $16.5M.
  • Eversept Partners added most to Community Health Systems in Q1 2023, an estimated $37.3M increase.
  • Eversept Partners's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $27.1M.
  • Eversept Partners fully exited Sanofi in Q1 2023, selling an estimated $77.7M.
  • Eversept Partners's ten largest holdings make up 65% of its $1.43B portfolio in Q1 2023.
  • Eversept Partners opened 14 new positions and closed 20 in Q1 2023.
  • Eversept Partners's portfolio value rose 26% quarter-over-quarter to $1.43B.

Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.